The study attempts to conduct randomized double-blind controlled trials to understand whether daily exposure to microplastics (MPs) can cause potential impacts on human health, explore whether the intake of Lactiplantibacillus plantarum PD01 can alleviate potential obesity-related damages caused by MPs, and provide a scientific basis for the prevention and nutritional intervention of health hazards caused by MP exposure.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Fecal microplastics (MPs) levels as assessed by Py-GC/MS
Timeframe: Up to 2 months
Gut microbiota composition as assessed by Fecal Metagenomics
Timeframe: Up to 2 months
Blood metabolic profiles as assessed by Blood Metabolomics
Timeframe: Up to 2 months
Inflammatory cytokines and immune markers
Timeframe: Up to 2 months
Blood biochemical indicators as assessed by the Mindray BS200 automatic biochemical analyzer
Timeframe: Up to 2 months
Routine blood examination (Five-part differential)
Timeframe: Up to 2 months
Anthropometric and body composition indicators
Timeframe: Up to 2 months